REGULATORY REVIEW: Analyzing the NOPAIN Act

REGULATORY REVIEW

A physician in a white lab coat examines a patient's hand and wrist during a clinical consultation, with anatomical charts visible on the wall in the background.

Analyzing the NOPAIN Act

Postoperative non-opioid alternatives receive separate reimbursement through 2027

BY KARA NEWBURY | APRIL 2026

The 2026 final payment rule for ASCs and hospital outpatient departments (HOPD) expanded the number of non-opioid postoperative pain relief treatment codes eligible for reimbursement under the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act. As of January 2026, there are 18 non-opioid alternatives available for separate Medicare reimbursement under the act, an increase from 11 codes that were eligible in 2025.

To read this article, you have to be a member of ASCA or subscribe to ASC Focus magazine.

Sign in > Join >Subscribe >